First Booster of SARS-COV-2 mRNA Vaccine Is Not Associated With Alloimmunization and Subclinical Injury of Kidney Allograft

Transplantation. 2023 Feb 1;107(2):e62-e64. doi: 10.1097/TP.0000000000004421. Epub 2022 Oct 29.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allografts
  • Anemia, Hemolytic, Autoimmune*
  • Antibodies, Viral
  • COVID-19 Vaccines* / administration & dosage
  • COVID-19* / prevention & control
  • Humans
  • Kidney
  • SARS-CoV-2
  • mRNA Vaccines

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines

Associated data

  • EudraCT/EudraCT 2022-000319-30
  • ClinicalTrials.gov/NCT05483725